CD4 and tuberculosis: Additional longitudinal studies of larger cohorts of HIV-uninfected patients with active TB disease are required to closely monitor PD-1 expression on Mtb-specific CD4 T cells to evaluate the utility of PD-1 as a biomarker for treatment response, and as a potential predictor of relapse of reinfection.